Journal profile · Medicine-Infectious Diseases
Vacunas
ISSN 1576-9887 · eISSN 1578-8857 · Elsevier
FollowGet an email when its zone, impact factor or warning status changes
Vacunas: subscription journal; APC about USD 2,960; review about 63 days (submission to acceptance, publisher); 159 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Vacunas is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Vaccine Coverage and Hesitancy, Bacterial Infections and Vaccines and Influenza Virus Research Studies, together about 41.4% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Revista Oficial de la Asociación Española de Vacunología (AEV)Vacunas publica artículos de investigación relacionados con el campo de las enfermedades inmunoprevenibles en humanos y aquellas con potencial zoonótico en animales. Prioriza los aspectos asociados con la planificación y evaluación, incluyendo la epidemiología de las enfermedades prevenibles por inmunización, el desarrollo de programas de vacunación y la evaluación de la eficacia, efectividad y eficiencia de las vacunaciones. Acepta artículos tanto en español como en inglés. Las áreas de interés de la revista son las siguientes:Desarrollo y evaluación de vacunas Epidemiología de enfermedades inmunoprevenibles Aspectos históricos, regulatorios y de utilización comercial Tecnología de vacunas, vectores, adyuvantes e inmunomoduladores Políticas de salud pública y programas de vacunación Inmunología de las vacunas y mecanismos de acción Mecanismos de inmunología relacionados con la vacunación Seguridad, eficacia y efectividad de las vacunas Reticencia y aceptación de las vacunas Vacunas para enfermedades crónicas, autoinmunes, alergias y enfermedades no transmisibles Vacunas veterinarias para la salud animal bajo la perspectiva de One Health-Una Salud Vacunas publishes research articles related to the field of vaccine-preventable diseases in humans and those with zoonotic potential in animals. It places special emphasis on aspects associated with planning and evaluation, including the epidemiology of vaccine-preventable diseases, the development of vaccination programs, and the evaluation of the efficacy, effectiveness, and efficiency of vaccinations. It accepts articles in both Spanish and English. The areas of interest of the journal are as follows: Vaccine development and evaluation Epidemiology of vaccine-preventable diseases Regulatory affairs and commercial utilization and historical background of vaccines Vaccine technology, vectors, adjuvants, and immunomodulators Public health policies and vaccination programs Vaccine immunology and mechanisms of action Immunological mechanisms Vaccine safety, efficacy, and effectiveness Vaccine hesitancy and acceptance Vaccines for chronic conditions, autoimmune diseases, allergies, and non-communicable diseases Veterinary vaccines for animal health from a One Health perspective
From the journal's Aims & Scope
Research area (LetPub): Medicine-Infectious Diseases
Editor-in-chief Núria TornerPublisher website
Editorial board by country: none in mainland China; most named Spain 38, Belgium 3, United States 2, Italy 1, Brazil 1 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Vaccine Coverage and HesitancySocial Sciences23.5%
- Bacterial Infections and VaccinesImmunology and Microbiology10.5%
- Influenza Virus Research StudiesMedicine7.4%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.7%
- Intramuscular injections and effectsMedicine6.5%
- Pneumonia and Respiratory InfectionsMedicine5.2%
- Immune responses and vaccinationsImmunology and Microbiology4.1%
- Virology and Viral DiseasesMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Infectious Diseases | Q3 | 191/361 | 47th |
| Immunology | Q3 | 170/243 | 30th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 3.1LetPub ·
- CiteScore (publisher)
- 3.1Publisher website ·
- SJR 2026-06
- 0.25LetPub ·
- SNIP 2026-06
- 0.33LetPub ·
- h-index
- 19OpenAlex ·
- i10-index
- 67OpenAlex ·
- 2-year mean citedness
- 0.91OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,268 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 38 | 4 | 224 |
| 2025 | 159 | 2 | 294 |
| 2024 | 52 | 4 | 381 |
| 2023 | 61 | 18 | 380 |
| 2022 | 137 | 60 | 371 |
| 2021 | 44 | 25 | 212 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
63 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 63 daysPublisher website ·
- Acceptance to publication
- 36 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,960 / EUR 2,700 / GBP 2,370 / JPY 367,130 | — | — | |
| Publisher website | USD 3,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted6
- letters to the editorRegardless of the type of article or the section of this journal, authors must always include on the first page of the article, in addition to the title, author…Length not stated
- original articleRegardless of the type of article or the section of this journal, authors must always include on the first page of the article, in addition to the title, author…Length not stated
- originalsOriginals: Research works on the immunogenicity, efficacy, effectiveness and safety of vaccines are accepted, as well as those on the microbiology, epidemiology…Length not stated
- other sectionsOther sections: The Journal includes other sections, such as Editorials, Reviews. Special Articles, vaccination strategies, Questions and Answers, Conferences a…Length not stated
- short communicationRegardless of the type of article or the section of this journal, authors must always include on the first page of the article, in addition to the title, author…Length not stated
- vaccine developmentVaccine Development: The section aims to provide expert analysis on vaccine development and challenges of different classes of biopharmaceuticals, including mon…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Peer review: single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Before you submit
Five checks before submitting to Vacunas
- 1ScopeRecent output centres on Vaccine Coverage and Hesitancy, Bacterial Infections and Vaccines.Check scope
- 2Article type and formatAbstract: ≤ 250 words.Submission rules
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
- 4FeesUSD 2,960 (OpenAlex)Fee details
- 5Expected review time63 days · Publisher-reported, submission to acceptanceReview data
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 1576-9887
- Electronic ISSN
- 1578-8857
- Society / sponsor
- Asociación Española de Vacunología
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Vacunas
How long does peer review take at Vacunas?
The publisher reports about 63 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Vacunas based?
Of the 48 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (38), Belgium (3) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Vacunas?
According to LetPub and DOAJ records, Vacunas is indexed in Scopus.
Is Vacunas open access, and what is the APC?
Vacunas is a subscription journal. APC about USD 2,960.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .